Quantcast
Get breaking news alerts via email

Click here to manage your alerts
(Steve Griffin | The Salt Lake Tribune) Susan Thomas of, Logan, Utah, talks with the media after becoming the first patient in the state to be implanted with a new leadless pacemaker which is the world's first retrievable, non-surgical pacing device for heart patients. Cardiologists, including Jared Bunch, left, at the Intermountain Medical Center Heart Institute in Murray implanted the device in the 72-year-old woman on July 28. The new leadless cardiac pacemaker is 10 percent the size of a conventional pacemaker and is the least invasive cardiac pacing device available today. It contains no wires (leads), which reduces complications from infections and lead failure and improves patient mobility and comfort. Thomas and doctors talked to the media at the hospital in Salt Lake City Monday, Aug. 11, 2014
Logan woman becomes first Utah patient to get tiny new pacemaker
Health » Logan woman is the first Utahn to receive the new device, which is in clinical trials.
First Published Aug 11 2014 05:21 pm • Last Updated Aug 11 2014 09:53 pm

A Logan woman and her cardiologist said Monday that a new, small pacemaker that keeps her heart beating steadily was implanted without surgery two weeks ago at Intermountain Medical Center in Murray.

Susan Thomas, 72, became the first patient in Utah to receive the new pacemaker, a Nanostim pacing device.

Join the Discussion
Post a Comment

The pacemaker is in clinical trials and has not yet been approved by the Food and Drug Administration. Intermountain is seeking other candidates who want to participate.

But Thomas is already a fan.

Thomas said she was in the hospital overnight and went to Flaming Gorge with her family a couple days later.

Two weeks later, she has more energy. "I’m able to get around better," she said. "I can stand up for the most part without being dizzy. It’s just been a lifesaver. I know it’s there, but I really don’t even feel this. It’s just part of my body now."

The study began in February, and has enrolled 121 people so far in about 50 locations in the United States and Canada. It continues until next June.

"This is the smallest pacemaker that is available for human use," said cardiologist Jared Bunch, of Intermountain Medical Center. "Instead of making an incision or doing surgery in the chest, this is advanced through a vein up into the heart and then it screws into the heart."

Traditional pacemakers are implanted during surgery below the collar bone and attached to muscle. Connected wires are threaded into the heart to deliver electric stimulation.

Those wires, or leads, are the most challenging component of most pacemakers, Bunch said. The Nanostim eliminates the need for them.


story continues below
story continues below

The new pacemaker is smaller than a AAA battery, less than 10 percent the size of a typical pacing device.

Surgeons insert it via a catheter in a vein near the groin. Once it is implanted in the right ventricle, the catheter is removed. The patient is put under anesthesia but receives no stitches.The Nanostim, developed by St. Jude Medical Inc., is wireless and communicates remotely with a computer in the hospital that allows doctors to monitor or change the strength and frequency of the electric shocks.

The device is 90 percent battery and its life depends on how often it’s used. If it paces 25 percent of the time, it will last about 18 years, Bunch said. If it paces 100 percent of the time, it will last only 10 to 12 years.

Existing pacemakers typically last that long, said Ravi Ranjan, a cardiologist at the University of Utah. More than 95 percent last more than 10 years, he said.

Ranjan said the new device is "niche technology" because the number of patients who would benefit from Nanostim is small compared to the number of people who need a pacemaker.

One of its limitations is it can pace only one chamber. Ranjan said 80 to 90 percent of patients need a dual-chamber pacemaker.

The device has previously been available in Europe through its first trial, which enrolled 33 patients.

A similar device, Micra Transcatheter Pacing System, developed by Medtronic Inc., also is in clinical trials in the United States and Europe.

Anyone interested in enrolling in the trial at Intermountain Heart Institute can call Jared Bunch or Jeff Osborne at Intermountain Medical Center at 801-507-3513.

dmanley@sltrib.com

Next Page >


Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment


About Reader Comments


Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Videos
Jobs
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.